STO:VITR

Vitrolife AB (publ) · STO · Healthcare · SEK · FY for 2025

Figures on this page computed 2026-11-08 13:05 UTC

Last close

n/aSEK

Market data

n/aP/E
We do not hold this figure for this company, so there is nothing to place.
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
SEK
- computed
- Computed from the filing for 2025
n/aROIC
We do not hold this figure for this company, so there is nothing to place.
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
-145.7%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
13.4%FCF margin
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
0.20Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
SEK
- Computed from the filing for 2025
- Computed from the filing for 2025
0.9%Dividend yield
Source
computed
Taken on
2026-11-08
Reported in
SEK
- computed

Growth is the furthest below its sector's middle: 0.41 against 0.50 on the market's range.

All from 100

lens 2 of 9

Sales

402

2016-12-31 to 2025-12-31100 at the start402

Sales: 100.00 on 2016-12-31 to 401.82 on 2025-12-31, up 302%.

Profit

-2,633

2016-12-31 to 2025-12-31100 at the start-2,633

Profit: 100.00 on 2016-12-31 to -2633.32 on 2025-12-31, down 2733%.

Shares in issue

125

2016-12-31 to 2025-12-31100 at the start125

Shares in issue: 100.00 on 2016-12-31 to 124.76 on 2025-12-31, up 25%.

Sales is at 402, Profit is at -2633, Shares in issue is at 125, against 100 in 2016.

Sales is at 402, Profit is at -2633, Shares in issue is at 125, against 100 in 2016.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales, where the first year is 100402
Source
computed
Statement
income
Fiscal year
2025
Reported in
SEK
Profit, where the first year is 100-2,633
Source
computed
Statement
income
Fiscal year
2025
Reported in
SEK
Shares in issue, where the first year is 100125
Source
computed
Statement
income
Fiscal year
2025
Reported in
SEK